% | $
Quotes you view appear here for quick access.

Actavis plc Ordinary Shares Message Board

  • ntlslp Apr 28, 2014 11:00 PM Flag

    Attacking the FDA a good idea for a drug company?

    Will this buy them friends in the Federal Government considering they are also the poster child for tax avoidance? Noose is tightening on American corporate. tax avoiders, not popular with Republicans or Dems, will be rectified soon. Taxes on earnings resulting from sales in the domestic market less applicable expenses proportional to each nation looks like the way it's going.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Yes, I agree...Although why would the FDA grant exclusive rights to Teva for the drug...Once it goes generic, can't anyone qualified make the alternative drug?

      Try not to bite the hand that approves you!

      • 1 Reply to kurtis4hyr
      • Gilead (GILD) is one of the hottest stocks on the market right now and it is even more intriguing because of its valuations. With a forward P/E of just over 11, this stock epitomizes both value and growth. At around $81/share there is plenty of upside left in this stock. Of the 24 analysts covering the stock, there are 21 buy recommendations with an average price target around $100/share.

        Sentiment: Strong Buy

298.980.00(0.00%)Jun 12 4:03 PMEDT